Samsung Bioepis’ Enbrel biosimilar secures European Commission approval
The approval follows a positive opinion by the European Medicines Agency’s Committee for Medicinal Products for Human Use. In a phase 3 clinical trial, Benepali showed comparable safety
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.